Infusion Investors
Thousand Oaks, US · Founded 2019 · Delaware LLC
Founders & leadership
JN
James NadauldNamed on SEC filing
NS
Nick SmithNamed on SEC filing
MW
Michael WilsteadNamed on SEC filing
CK
Clara KrigerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$7.2M disclosed across 1 round · 2019
▶$7.2MraisedAug 2019 · 12 investors · Other Health CareRule 506(b)
▶$7.2MraisedAug 2019 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Promoter Cimarron Healthcare Investments I, LPPromoter
- James NadauldExecutive Officer, Director
- Nick SmithDirector
- Michael WilsteadDirector
- Clara KrigerDirector
- Offering amount
- $7.2M
- Amount sold
- $7.2M
- First sale
- Aug 2019
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Infusion Investors raised?
- Infusion Investors has disclosed $7.2M raised across 1 round.
- Where is Infusion Investors headquartered?
- Infusion Investors is headquartered in Thousand Oaks, US.